CannabisNewsBreaks

TuesdayDec 20, 2022 12:01 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Files Updated Life Sciences Presentation

India Globalization Capital (NYSE American: IGC) today announced the filing of a life sciences presentation with the SEC on Form 8K. The presentation, available on the SEC website as well as published to IGC’s website, provides an overview of the company’s initiatives in life sciences. These include IGC’s focus on low-dose THC-based drug formulation and disease treatment and its various lines of cannabinoid-based consumer products. To view the full press release, visit https://cnw.fm/quvdW About India Globalization Capital Inc. India Globalization Capital, through its subsidiary IGC Pharma LLC, develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s,…

Continue Reading

MondayDec 19, 2022 12:56 pm

CannabisNewsBreaks – REZYFi Inc. Tailoring Financing Packages to Meet Unique Needs of Cannabis Businesses

REZYFi seeks to fill an existing funding gap, where cannabis business operators face perpetual difficulty accessing capital in the form of loans and mortgages from Federal Deposit Insurance Corporation (“FDIC”)-insured banks and financial institutions. “REZYFi regards itself as a real estate-oriented mortgage company servicing the needs of both traditional and non-traditional consumers and businesses, but with a primary focus on the cannabis sector. The company mainly offers mortgage origination and specialized financing to licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies,” a recent article reads. “Leveraging its team’s significant experience in a wide…

Continue Reading

FridayDec 16, 2022 3:21 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (‘CBD’) may potentially have therapeutic utility against diabetes,” a recent article reads. “Lexaria is optimistic that its DehydraTECH-CBD will yield notable results from this study, especially having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study. There is a strong connection between heart disease, hypertension and diabetes, with hypertension proving to…

Continue Reading

FridayDec 16, 2022 10:26 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and management information circular. Specifically, the election of directors was held, and shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders. Those directors included Eric Adams, Andrew Hull, Janet Grove, Bryan Baldasare, and Nicole Lemerond. To view…

Continue Reading

WednesdayDec 14, 2022 1:09 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Positioned in Rapidly Growing Market Estimated to Hit $172B in 2027

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods. The company today announced a new report from KD Market Insights indicating that the market for controlled environment agriculture (“CEA”) is estimated to increase at a compound annual growth rate (“CAGR”) of 18.7% to reach $172 billion in 2027. The growth was attributed, in part, to an increase in world population, loss of agricultural land, as well as a strong demand for local foods. The report notes “remarkable advantages of CEA,” that include faster plant growth throughout the year, which allows for larger yields. “In a controlled environment,…

Continue Reading

TuesdayDec 13, 2022 10:30 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announced that Jonathan Tegge, a member of Brio Financial Group, will shoulder the role of interim CFO effective Dec. 12, 2022. The announcement accompanied the news that InMed has signed a service contract with Brio Financial Group to provide senior financial leadership and bookkeeping services. A financial and management consulting group based in New Jersey, Brio outsources financial management and financial reporting support to small- and middle-market entities. Currently, the Brio team provides consulting services to some 50 private and publicly traded…

Continue Reading

MondayDec 12, 2022 11:45 am

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Issues Update on Strategic Vision

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, today provided an update to current and prospective shareholders. According to the update, the company is targeting a leadership role in product manufacturing and wholesale distribution in the legal cannabis marketplace in California. The company believes it has a built-in edge in targeting this niche, which offers a value proposition to small and medium sized grow operations and retailers. “The industry has effectively over-verticalized and there’s rampant inefficiency that drives value destruction for smaller producers and for the whole…

Continue Reading

FridayDec 09, 2022 12:04 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces $5M Registered Direct Offering

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its entry into securities agreements with institutional investors for the purchase and sale of 12,500,000 of the company’s common shares, pursuant to a registered direct offering, and warrants to purchase up to 12,500,000 common shares. According to the update, the combined purchase price for one common share and one warrant will be $0.40. Aggregate proceeds from the offering will be approximately $5.0 million, from which the company expects to use net proceeds for capital expenditures, to increase operating capacity, as well as…

Continue Reading

ThursdayDec 08, 2022 1:50 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Latest DehydraTECH-CBD Study May Be 1st to Evidence Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs, has, since inception, been committed to addressing severe unmet patient needs. Hypertension has been one of its main focus areas. “Lexaria continues to move forward, most recently with the success in its latest human clinical study, HYPER-H21-4. The study may be the first to evidence a sustained drop in blood pressure in normally active patients following multiple weeks of oral cannabidiol (‘CBD’) therapy using the company’s patented DehydraTECH(TM) technology,” reads a recent article. “Since Lexaria began developing DehydraTECH…

Continue Reading

ThursdayDec 08, 2022 12:44 pm

CannabisNewsBreaks – REZYFi Inc. Leveraging Corporate Strengths to Capitalize on Growth in Multiple Verticals

REZYFi is positioned as the first cannabis mortgage banker in the United States. With most traditional lenders reticent to serve the state-licensed cannabis industry, REZYFi stands distinct. “REZYFi services the needs of both traditional and non-traditional consumers and businesses. The company is targeting markets that include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects,” a recent article reads. “REZYFi operates under two wholly owned subsidiaries –…

Continue Reading